Platelet-Derived Growth Factor Receptor-β Expression in Human Peritoneum
Harald Seeger(University Hospital of Zurich), Stephan Segerer(Kantonsspital Aarau), Maja Lindenmeier(University of Zurich), Dagmar Biegger(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rudolf P. Wüthrich(University of Zurich), Mark Dominik Alscher(Robert Bosch Hospital), Péter Fritz(Robert Bosch Hospital), Joerg Latus(Robert Bosch Hospital), Niko Braun(Stuttgart Observatory), Ilka Edenhofer(University of Zurich)
Cited by 8
Related Papers
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
|Nephrology Dialysis Transplantation|2005|285
The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients
|Nephrology Dialysis Transplantation|2005|233
Use of phosphate-binding agents is associated with a lower risk of mortality
|Kidney International|2013|158
Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
|PLoS ONE|2016|102
Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
|Kidney International|2014|94